Search Results 7781-7790 of 33759 for oral

1. Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301 - Mayo Clinic

   Approved forms of contraception include hormonal intrauterine devices or hormonal contraceptives (oral birth control pills, Depo-Provera®, patch, or other ...

2. A Study to Evaluate CB-839 HCl in Combination With Carfilzomib and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma - Mayo Clinic

   Known GI disease or GI procedure that could interfere with the oral absorption or tolerance of CB-839 HCl (telaglenastat) including difficulty swallowing ...

3. A Study of Ibrutinib as Prophylaxis for Chronic Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (allo-HCT) - Mayo Clinic

   ... . Male and female subjects agreeable to using both a highly effective method of birth control (for example, implants, injectables, combined oral ...

4. Obstructive sleep apnea - Doctors and departments - Mayo Clinic

   Departments that treat this condition. Dental Specialties · Neurology · Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric ...

5. A Study of Intratumoral Injection of Autologous Dendritic Cells after High-Dose Conformal External Beam Radiotherapy in Patients with Unresectable Liver Cancer - Mayo Clinic

   Corticosteroids ≤2 weeks prior to registration, including oral, IV, subcutaneous, or inhaled routes of administration. NOTE: Patients on chronic ...

6. A Study to Determine the Outcomes of Patients With Localized B Cell Lymphoblastic Lymphoma (B-LLy) When Treated With Standard Risk B-ALL Therapy - Mayo Clinic

   - DS and non-DS B-LLy patients must not have received > 48 hours of oral or IV steroids within 4 weeks of diagnosis. - B-ALL patients who do not have ...

7. HPV infection may cause throat, mouth cancer - Mayo Clinic News Network

   More than 54,000 adults in the U.S. are diagnosed with oral cavity and oropharyngeal cancer each year. Men are twice as likely than women to be diagnosed ...

8. A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of RO7303509 in Participants With Systemic Sclerosis - Mayo Clinic

   Patients on stable doses of MMF, MTX, HCQ, AZA, SSZ, TCZ, and/or oral corticosteroids should not have the prospective intent to discontinue or change the ...

9. Diabetic nephropathy (kidney disease) - Doctors and departments - Mayo Clinic

   Research at Mayo Clinic in diabetic nephropathy includes developing new diagnostic and treatment tools, such as oral medicines that may help stop or delay ...

10. Sharing Mayo Clinic: Facing death and fighting back

    He'll have to take an oral antifungal medication for the rest of his life. Given the seriousness of Danny's infection, his outcome is remarkable, according ...